COMP <GO>
EHC vs UNH // EV/EBITDA & P/E VALUATION
Encompass Health Corporation (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: EHC 9
— UNH 4
▲ EV/EBITDA & P/E VALUATION LEADER: EHC
LAST: $131.49 (+7.70%) • MKT CAP: $12.97B
valuation
15.8x
LAST: $410.91 (+0.94%) • MKT CAP: $368.83B
valuation
16.4x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EHC VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | EHC | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 88.57% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 13.80% | 11.47% | +2.33 | EHC | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 15.8x | 16.4x | -0.65 | EHC | /valuation <GO> |
| Free Cash Flow Yield | 2.92% | 6.48% | -3.56 | UNH | /fcf-yield <GO> |
| Operating Margin | 11.60% | 4.82% | +6.78 | EHC | /operating-margins <GO> |
| Net Profit Margin | 9.50% | 3.14% | +6.36 | EHC | /net-margins <GO> |
| Revenue Growth (YoY) | 10.50% | 6.46% | +4.04 | EHC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.55% | 2.28% | -1.73 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.47 | 3.12 | +0.35 | EHC | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 7/9 | +2.00 | EHC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.74% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 60.3 | 59.2 | +1.10 | EHC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.90 | 0.33 | +0.57 | EHC | /macro-sensitivity <GO> |
| Forward P/E Multiple | 21.3x | 17.1x | +4.21 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $12.97B | $368.83B | -$355.86B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | EHC REV | UNH REV | EHC GROSS % | UNH GROSS % | EHC FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.94B | $447.57B | — | 88.7% | — | $16.07B |
| FY 2024 | $5.37B | $400.28B | — | 88.3% | — | $20.70B |
| FY 2023 | $4.80B | $371.62B | — | 89.6% | — | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EHC // BETA 0.90
UNH // BETA 0.33